RHÖN-KLINIKUM AG Shows Steady Progress in Q3 2024

RHÖN-KLINIKUM AG reports consistent growth in the first nine months of 2024. The company saw an increase in consolidated revenues by EUR 82.1 million, reaching EUR 1,171.1 million compared to the prior year period. Meanwhile, the consolidated profit rose by 27.7%, amounting to EUR 30.4 million, with EBITDA growing by 2.3% to EUR 75.1 million. The number of treated patients reached 688,787, marking a 3.6% increase from last year.

Chairman Prof. Dr. Tobias Kaltenbach emphasized strategic measures for stable performance in a challenging market and preparation for hospital reform. The focus remains on facility specialization, treatment quality, and reinvestment in staff and infrastructure.

The outlook for 2024 confirms expected revenues of approximately EUR 1.6 billion and an EBITDA forecast of EUR 110 to 120 million, despite uncertainties from global economic conditions and inflation.